메뉴 건너뛰기




Volumn 13, Issue 10, 2004, Pages 1640-1645

Prostate-specific antigen and free prostate-specific antigen in the early detection of prostate cancer: Do combination tests improve detection?

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

EID: 4944237212     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (32)

References (18)
  • 1
    • 0028801975 scopus 로고
    • A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer
    • Gann PH, Hennekens CH, Stampfer MJ. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA 1995;273:289-94.
    • (1995) JAMA , vol.273 , pp. 289-294
    • Gann, P.H.1    Hennekens, C.H.2    Stampfer, M.J.3
  • 2
    • 0030913316 scopus 로고    scopus 로고
    • Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements
    • Catalona WJ, Smith DS, Ornstein DK. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements. JAMA 1997;277:1452-5.
    • (1997) JAMA , vol.277 , pp. 1452-1455
    • Catalona, W.J.1    Smith, D.S.2    Ornstein, D.K.3
  • 3
    • 0038497523 scopus 로고    scopus 로고
    • Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen
    • Punglia RS, D'Amico AV, Catalona WJ, Roehl KA, Kuntz KM. Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen. N Engl J Med 2003;349:335-42.
    • (2003) N Engl J Med , vol.349 , pp. 335-342
    • Punglia, R.S.1    D'Amico, A.V.2    Catalona, W.J.3    Roehl, K.A.4    Kuntz, K.M.5
  • 4
    • 0028800933 scopus 로고
    • Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening
    • Catalona WJ, Smith DS, Wolfert RL, et al. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 1995;274:1214-20.
    • (1995) JAMA , vol.274 , pp. 1214-1220
    • Catalona, W.J.1    Smith, D.S.2    Wolfert, R.L.3
  • 5
    • 0030447621 scopus 로고    scopus 로고
    • Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: Influence of total PSA, prostate volume, and age
    • Partin AW, Catalona WJ, Southwick PC, Subong EN, Gasior GH, Chan DW. Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age. Urology 1996;48:55-61.
    • (1996) Urology , vol.48 , pp. 55-61
    • Partin, A.W.1    Catalona, W.J.2    Southwick, P.C.3    Subong, E.N.4    Gasior, G.H.5    Chan, D.W.6
  • 6
    • 0036093267 scopus 로고    scopus 로고
    • Strategies combining total and percent free prostate specific antigen for detecting prostate cancer: A prospective evaluation
    • Gann PH, Ma J, Stampfer MJ. Strategies combining total and percent free prostate specific antigen for detecting prostate cancer: a prospective evaluation. J Urol 2002;167:2427-34.
    • (2002) J Urol , vol.167 , pp. 2427-2434
    • Gann, P.H.1    Ma, J.2    Stampfer, M.J.3
  • 7
    • 0034048942 scopus 로고    scopus 로고
    • Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer
    • Brawer MK, Cheli CD, Neaman IE, et al. Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer. J Urol 2000;163:1476-80.
    • (2000) J Urol , vol.163 , pp. 1476-1480
    • Brawer, M.K.1    Cheli, C.D.2    Neaman, I.E.3
  • 8
    • 0033992457 scopus 로고    scopus 로고
    • Examination of the 3 molecular forms of serum prostate specific antigen for distinguishing negative from positive biopsy: Relationship to transition zone volume
    • Stamey TA, Yemoto CE. Examination of the 3 molecular forms of serum prostate specific antigen for distinguishing negative from positive biopsy: relationship to transition zone volume. J Urol 2000;163:119-26.
    • (2000) J Urol , vol.163 , pp. 119-126
    • Stamey, T.A.1    Yemoto, C.E.2
  • 11
    • 2942658010 scopus 로고    scopus 로고
    • Combining biomarkers to detect disease with application to prostate cancer
    • Etzioni R, Kooperberg C, Pepe MS, Smith R, Gann PH. Combining biomarkers to detect disease with application to prostate cancer. Biostatistics 2003;4:523-38.
    • (2003) Biostatistics , vol.4 , pp. 523-538
    • Etzioni, R.1    Kooperberg, C.2    Pepe, M.S.3    Smith, R.4    Gann, P.H.5
  • 12
    • 0033638552 scopus 로고    scopus 로고
    • Identifying combinations of cancer markers for further study as triggers of early intervention
    • Baker SG. Identifying combinations of cancer markers for further study as triggers of early intervention. Biometrics 2000;56:1082-7.
    • (2000) Biometrics , vol.56 , pp. 1082-1087
    • Baker, S.G.1
  • 14
    • 0041488899 scopus 로고    scopus 로고
    • Semiparametric regression for the area under the receiver operating characteristic curve
    • Dodd LE, Pepe MS. Semiparametric regression for the area under the receiver operating characteristic curve. J Am Stat Assoc 2003;98:409-17.
    • (2003) J Am Stat Assoc , vol.98 , pp. 409-417
    • Dodd, L.E.1    Pepe, M.S.2
  • 15
    • 0001529952 scopus 로고    scopus 로고
    • Prospective evaluation of percent free-PSA and complexed-PSA for early detection of prostate cancer
    • Partin AW, Brawer MK, Subong EN, et al. Prospective evaluation of percent free-PSA and complexed-PSA for early detection of prostate cancer. Prostate Cancer Prostatic Dis 1998;1:197-203.
    • (1998) Prostate Cancer Prostatic Dis , vol.1 , pp. 197-203
    • Partin, A.W.1    Brawer, M.K.2    Subong, E.N.3
  • 16
    • 0036229722 scopus 로고    scopus 로고
    • Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer
    • discussion 23-4
    • Okihara K, Cheli CD, Partin AW, et al. Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer. J Urol 2002;167:2017-23; discussion 23-4.
    • (2002) J Urol , vol.167 , pp. 2017-2023
    • Okihara, K.1    Cheli, C.D.2    Partin, A.W.3
  • 17
    • 0032550630 scopus 로고    scopus 로고
    • Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: A prospective multicenter clinical trial
    • Catalona WJ, Partin AW, Slawin KM, et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA 1998;279:1542-7.
    • (1998) JAMA , vol.279 , pp. 1542-1547
    • Catalona, W.J.1    Partin, A.W.2    Slawin, K.M.3
  • 18
    • 17144466104 scopus 로고    scopus 로고
    • Usefulness of the ratio free/total prostate-specific antigen in addition to total PSA levels in prostate cancer screening
    • Reissigl A, Klocker H, Pointner J, et al. Usefulness of the ratio free/total prostate-specific antigen in addition to total PSA levels in prostate cancer screening. Urology 1996;48:62-6.
    • (1996) Urology , vol.48 , pp. 62-66
    • Reissigl, A.1    Klocker, H.2    Pointner, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.